Brief: Medexus Pharmaceuticals Announces Clear Path To FDA Decision Following Medac’S Type A Meeting With FDA On Treosulfan

Medexus Pharmaceuticals

02/12/2021 13:40

Dec 2 (Reuters) - Medexus Pharmaceuticals Inc  MDP.TO :
    * MEDEXUS PHARMACEUTICALS ANNOUNCES CLEAR PATH TO FDA
DECISION
FOLLOWING MEDAC’S TYPE A MEETING WITH FDA ON TREOSULFAN
    * MEDEXUS PHARMACEUTICALS INC - FINAL FDA DECISION EXPECTED
2 TO 6
MONTHS AFTER NDA RESUBMISSION
    * MEDEXUS PHARMACEUTICALS INC - MEDAC WILL CONTINUE TO FUND
REGULATORY COSTS UNTIL APPROVAL

Source text for Eikon:  ID:nGNXW7YLH 
Further company coverage:  MDP.TO 

 ((Reuters.Briefs@thomsonreuters.com;))